These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing. Beck A; Tesh RB; Wood TG; Widen SG; Ryman KD; Barrett AD J Infect Dis; 2014 Feb; 209(3):334-44. PubMed ID: 24141982 [TBL] [Abstract][Full Text] [Related]
5. Genetic variability among yellow fever virus 17D substrains. Galler R; Post PR; Santos CN; Ferreira II Vaccine; 1998; 16(9-10):1024-8. PubMed ID: 9682354 [TBL] [Abstract][Full Text] [Related]
6. Structural and Nonstructural Genes Contribute to the Genetic Diversity of RNA Viruses. Collins ND; Beck AS; Widen SG; Wood TG; Higgs S; Barrett ADT mBio; 2018 Oct; 9(5):. PubMed ID: 30377281 [TBL] [Abstract][Full Text] [Related]
7. Attenuation of wild-type yellow fever virus by passage in HeLa cells. Barrett AD; Monath TP; Cropp CB; Adkins JA; Ledger TN; Gould EA; Schlesinger JJ; Kinney RM; Trent DW J Gen Virol; 1990 Oct; 71 ( Pt 10)():2301-6. PubMed ID: 2230735 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein. Schlesinger JJ; Brandriss MW; Monath TP Virology; 1983 Feb; 125(1):8-17. PubMed ID: 6187129 [TBL] [Abstract][Full Text] [Related]
9. Structure-Function of the Yellow Fever Virus Envelope Protein: Analysis of Antibody Epitopes. Davis EH; Barrett ADT Viral Immunol; 2020; 33(1):12-21. PubMed ID: 31682201 [TBL] [Abstract][Full Text] [Related]
10. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection Douam F; Soto Albrecht YE; Hrebikova G; Sadimin E; Davidson C; Kotenko SV; Ploss A mBio; 2017 Aug; 8(4):. PubMed ID: 28811340 [TBL] [Abstract][Full Text] [Related]
11. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice. Ryman KD; Ledger TN; Campbell GA; Watowich SJ; Barrett AD Virology; 1998 Apr; 244(1):59-65. PubMed ID: 9581778 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of the 17D-204 yellow fever vaccine. Salmona M; Gazaignes S; Mercier-Delarue S; Garnier F; Korimbocus J; Colin de Verdière N; LeGoff J; Roques P; Simon F Vaccine; 2015 Oct; 33(41):5432-5436. PubMed ID: 26314624 [TBL] [Abstract][Full Text] [Related]
13. Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213. dos Santos CN; Post PR; Carvalho R; Ferreira II; Rice CM; Galler R Virus Res; 1995 Jan; 35(1):35-41. PubMed ID: 7754673 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the antigen distribution and tissue tropisms of three phenotypically distinct yellow fever virus variants in orally infected Aedes aegypti mosquitoes. McElroy KL; Girard YA; McGee CE; Tsetsarkin KA; Vanlandingham DL; Higgs S Vector Borne Zoonotic Dis; 2008 Oct; 8(5):675-87. PubMed ID: 18494601 [TBL] [Abstract][Full Text] [Related]
15. The phylogeny of yellow fever virus 17D vaccines. Stock NK; Boschetti N; Herzog C; Appelhans MS; Niedrig M Vaccine; 2012 Feb; 30(6):989-94. PubMed ID: 22197965 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine. Wang E; Ryman KD; Jennings AD; Wood DJ; Taffs F; Minor PD; Sanders PG; Barrett AD J Gen Virol; 1995 Nov; 76 ( Pt 11)():2749-55. PubMed ID: 7595382 [TBL] [Abstract][Full Text] [Related]
17. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice. Ryman KD; Xie H; Ledger TN; Campbell GA; Barrett AD Virology; 1997 Apr; 230(2):376-80. PubMed ID: 9143294 [TBL] [Abstract][Full Text] [Related]
18. E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence. Lee E; Lobigs M J Virol; 2008 Jun; 82(12):6024-33. PubMed ID: 18400851 [TBL] [Abstract][Full Text] [Related]
19. The yellow fever 17D virus as a platform for new live attenuated vaccines. Bonaldo MC; Sequeira PC; Galler R Hum Vaccin Immunother; 2014; 10(5):1256-65. PubMed ID: 24553128 [TBL] [Abstract][Full Text] [Related]
20. Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analyses of vaccines produced world-wide. Monath TP; Kinney RM; Schlesinger JJ; Brandriss MW; Brès P J Gen Virol; 1983 Mar; 64 Pt 3():627-37. PubMed ID: 6298349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]